Real moms, real GLP-1 talk
The First Month on a GLP-1: A Week-by-Week Guide
A week-by-week guide to starter doses, appetite changes, symptoms and the first follow-up, with realistic expectations from labels and clinical trials.
On this page
Why a whole month, not just week one
The first month is worth separating from a first-week account. I would use those four weeks to understand my prescription, notice whether eating and drinking remain manageable, and prepare for the next review. This guide draws on schedules and trials rather than a personal treatment diary. I would not expect a long-term average to tell me what my scale should show on day seven.
Some links earn us a referral fee, and I'll flag our featured partner.
Week 1: learn the starter-dose routine
You start low. On the semaglutide (Wegovy) schedule that's 0.25 mg a week — explicitly a starting dose "to reduce the likelihood of gastrointestinal symptoms," not the maintenance dose1. Tirzepatide (Zepbound) begins the same way, at 2.5 mg weekly as an initiation dose2. An early appetite or symptom response is not guaranteed. Most of what the medicine is doing is invisible: it slows how fast your stomach empties and dials down appetite signaling5.
Some people notice appetite changes early; others do not. I would avoid using either experience to change my own dose. A practical question is whether the injection day and support arrangements fit my week. If I needed to change the day, I would follow the specific product’s spacing instructions rather than improvise around a busy morning.
Week 2: notice changes without expecting a script
I would note what I can eat, whether I can keep fluids down and how symptoms relate to the injection, so my clinician has useful information instead of an expected week-two story5. There is no guaranteed week when “food noise” quiets; appetite effects and gastrointestinal symptoms vary.
The trade is that this is also when mild nausea can show up. In the big trials, nausea and diarrhea were the most common effects — and they were typically transient and mild-to-moderate, subsiding with time3. Smaller portions genuinely feel better than big meals when your stomach is emptying slowly, so lighter dinners aren't a diet rule here, they're comfort. Keep bland snacks in the diaper bag for you.
Week 3: still no dramatic scale drop — read this before you spiral
The well-known trial results are measured over more than a year, which is why a month-by-month timeline helps: around 15% average loss with semaglutide over 68 weeks3 and up to about 21% with the higher tirzepatide dose over 72 weeks4. I would not turn those averages into a four-week target or interpret one weigh-in as a verdict on the treatment.
I would review both response and tolerability with the prescriber. Less hunger alone does not prove the whole treatment plan is appropriate, and a stable scale alone does not establish failure. Symptoms, dose, nutrition and the reason for treatment belong in the same discussion.
Week 4: prepare for the next prescribing decision
After four completed weeks, the usual schedules may move to the next dose — semaglutide moves from 0.25 mg to 0.5 mg after four weeks1, and tirzepatide from 2.5 mg to 5 mg after four weeks2. This matters because the gastrointestinal side effects cluster during dose escalation rather than at a steady dose4. In plain terms: you might feel fine for three weeks, then get a little queasy again right after the bump. That pattern can occur during escalation, but significant symptoms should be reviewed before another increase.
I'd schedule the step-up week a touch lighter if you can, with the usual side-effect measures ready — nothing heroic, just don't plan the big family road trip for the day after. If the nausea is more than mild, or you get severe or persistent vomiting or real stomach pain, that's a call-your-clinician moment, not a tough-it-out one.
What I would have ready for the next review
- Week 1: My medication name, prescribed dose, administration instructions and contact details for help.
- Week 2: Notes on meals, fluids and symptoms, without assuming everyone follows the same sequence.
- Week 3: Questions about the trend and whether the current dose is tolerable.
- After four completed weeks: A clinician’s decision about whether the next dose is appropriate, rather than an automatic change.
I would also confirm month two’s full charge before renewal, because a first-month price is often not the ongoing one. CoreAge Rx, our featured partner, advertises the same price at every listed dose, but the selected plan's total still needs checking. MEDGm charges $179 for the first month of semaglutide injections and $299 a month after that, RxSpan MD labels its brand-medication prices first-month only, and Embody takes payment before the eligibility consult, with its $79 rate listed under a sale banner and no confirmed billing cycle. Those are the numbers I would want in writing before the first renewal date.
The first month includes assessment as well as treatment. I would ask how the next prescription is approved and how to get help if symptoms interfere with eating or drinking. A formulation with added ingredients should not be assumed to fix intolerance. Your first month, your dose and your history belong in a conversation with your own clinician — GLP-1s aren’t for use in pregnancy or while trying to conceive.
Frequently asked questions
How much weight will I lose in the first month on a GLP-1?
The trials do not establish a guaranteed first-month result. Starter doses and individual responses vary. Discuss tolerability, nutrition and response with your prescriber; one stable weigh-in does not establish treatment failure.
Why do I feel more nauseous again around week four?
Gastrointestinal symptoms can occur during escalation, but the usual first increase follows four completed weeks, not an automatic increase at the start of week four. Severe or persistent vomiting or stomach pain is a reason to call your clinician.
How is this different from the 'week 1' experience?
A first-month guide includes preparation for follow-up and the next prescribing decision. It does not imply that appetite, symptoms or weight must follow a fixed weekly sequence.
References
- Novo Nordisk (FDA prescribing information, via DailyMed) (2025). WEGOVY (semaglutide) injection — Dosage and Administration (0.25 mg starting dose, 4-week step-ups). U.S. National Library of Medicine, DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Eli Lilly (FDA prescribing information, via DailyMed) (2025). ZEPBOUND (tirzepatide) injection — Dosage and Administration (2.5 mg initiation, 5 mg after 4 weeks). U.S. National Library of Medicine, DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Singh G, Krauthamer M, Bjalme-Evans M. (2022). Wegovy (semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine. https://pubmed.ncbi.nlm.nih.gov/34706925/
One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.
Continue reading
Tired on a GLP-1? The Questions I Would Bring to My Clinician
How I would investigate fatigue during GLP-1 treatment: the limits of trial numbers, food intake, dehydration, sleep, low glucose and medication review.
ReadMissed a GLP-1 Shot? Check Wegovy and Zepbound’s Rules
Wegovy and Zepbound count missed doses differently. How to check the correct rule, avoid catch-up guesses and ask about restarting after a longer gap.
ReadGLP-1s and Alcohol: What Craving Research Shows
What small randomized trials show about GLP-1s and alcohol craving, what they do not establish, and questions about symptoms and other medicines.
ReadOzempic Face: What Weight-Loss Research Can Explain
What research can explain about facial changes after GLP-1 weight loss, which claims remain uncertain, and questions to ask about proposed solutions.
ReadUrine and Body-Odor Changes on a GLP-1: What to Ask
How to describe urine or body-odor changes during GLP-1 treatment, what remains uncertain, and the dehydration or infection symptoms needing advice.
ReadSulfur Burps on a GLP-1: Evidence, Relief and Warning Signs
What labels and research say about GLP-1 belching, why the sulfur explanation is less certain, and which accompanying symptoms warrant a call.
Read